乙化增加了PD-L1的表达,与TRAPPC4的相互作用和表面定位
Maria Anele Romeo1, Maria Saveria Gilardini Montani1, Roberta Santarelli1
1Department of Experimental Medicine, "Sapienza" University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
Discover oncology
|August 21, 2023
概括
酸 (VPA) 是一种HDAC抑制剂,通过增强基因转录和蛋白质乙化来增加胰腺癌细胞的PD-L1. 将VPA与像JQ-1这样的BRD4抑制剂结合起来,可能会改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 编程死亡配体1 (PD-L1) 对于癌细胞来说至关重要,以逃避免疫监测.
- 表观遗传修饰,包括乙化,影响PD-L1表达和局部化.
- 基斯脱乙酶 (HDAC) 抑制剂正在研究它们在癌症治疗中的潜力.
研究的目的:
- 为了研究VPA的作用,一个I/IIa类HDAC抑制剂,在胰腺癌中对PD-L1的表达.
- 阐明VPA诱导PD-L1上调的基础分子机制.
- 评估将VPA与BRD4抑制剂结合以增强抗癌效果的潜力.
主要方法:
- 用VPA和JQ-1 (BRD4抑制剂) 治疗胰腺癌细胞.
- 对PD-L1表面表达和基因转录的分析.
- 评估基质子和PD-L1蛋白质的乙化.
- 研究TRAPPC4相互作用和PD-L1循环的研究.
- 对联合治疗的细胞毒性进行评估.
主要成果:
- 在胰腺癌细胞上,VPA显著上调了表面PD-L1表达.
- 增加PD-L1转录与PD-L1基因的基因乙化相关.
- PD-L1蛋白的乙化增强了其与TRAPPC4的相互作用,促进了细胞膜循环.
- JQ-1 抵消了VPA诱导的PD-L1转录和表面表达.
- 组合治疗表明VPA细胞毒性增加.
结论:
- 在胰腺癌中,VPA通过表观遗传机制促进PD-L1表面表达,包括基因组和蛋白质乙化.
- 与VPA结合向BRD4可能是一个有希望的策略,以克服免疫逃避并提高治疗疗效.
- VPA的作用是特定于PD-L1的,不会影响PD-L2或巨细胞的PD-L1表达.
相关概念视频
Covalently Linked Protein Regulators
6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.9K
Phase II Reactions: Acetylation Reactions
266
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
266


